Your shopping cart is empty. Please add some items to your basket before proceeding.
P
2024
The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.
Report Code : A172697 | Pages : 256 | Category : Life Sciences
Price:
$3,570 $2,499 (30% Off)
License: Cloud Access
PDF, PPT, XLS
UPDATE AVAILABLE ON DEMAND
Enter Valid Email ID
Verification code has been sent to your email ID
By continuing, you agree to Allied Market Research Terms of Use and Privacy Policy
Advantages Of Our Secure Login
Easily Track Orders, Hassel free Access, Downloads
Get Relevent Alerts and Recommendation
Wishlist, Coupons & Manage your Subscription
Register and Earn 500 Loyalty Points
Have a Referral Code?
Enter Valid Referral Code
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.
